Keith R. Leonard, Director at Sienna Biopharmaceuticals, Inc. (SNNA), bought 100,000 shares at $2.50 ($250K) on 2019-02-22, disclosed to the SEC on 2019-02-26.
Open-market purchase of $250k SNNA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |
| SNNA | BUY | 2017-08-01 | $251K | — | Filing → |